Figure 3.
Expression of B3GNT8 and MGAT4A in frontal cortex from male rats treated for nine months with haloperidol decanoate or vehicle. Data are presented as the ratio of signal intensity of each target protein to intensity of valosin-containing protein (VCP) labeling from the same lane of the same blot. Bars represent means ± standard deviation. Chronic haloperidol treatment did not change expression of either B3GNT8 or MGAT4A.